Peter Hertel, PhD
- 2Articles
- 33.4KReads1
- 2014–2017Active
- 18Collaborators
- 196Citations2
About
Peter Hertel, PhD, has contributed to research on the use of aripiprazole once-monthly formulations in psychiatric conditions. His work includes studies on the maintenance treatment of bipolar I disorder and the acute treatment of schizophrenia, focusing on clinical trial methodologies such as randomized, double-blind, placebo-controlled designs. He has published on these topics between 2014 and 2017 in Psychiatrist.com journals.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
